Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Simple Structural Chromosomal Abnormalities in Advanced Stage of Ovarian Cancer

ANNA D. PANANI, CHRISTOS ARAVIDIS, ZOE KOSMAIDOU, ALEXANDROS RODOLAKIS and ARISTIDES ANTSAKLIS
In Vivo May 2009, 23 (3) 425-428;
ANNA D. PANANI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: apanani@med.uoa.gr
CHRISTOS ARAVIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ZOE KOSMAIDOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALEXANDROS RODOLAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARISTIDES ANTSAKLIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Ovarian cancer represents the leading cause of death among patients with gynaecological cancer. The identification of chromosomal abnormalities is a useful strategy toward understanding tumourigenesis and specific chromosomal associations. Since single chromosomal changes might be primary events implicated in the initiation of the neoplastic process, the aim of the present study was to investigate the presence of simple structural chromosomal changes in ovarian cancer. Materials and Methods: Reviewing on ascetic effusions samples cytogenetically studied by direct culture of tumour cells and a G-banding technique, two ovarian cancer cases were found which presented simple structural chromosomal abnormalities. Results: The first case presented an abnormal clone of cells with an acquired pericentric inversion of chromosome 9, inv(9)(p11q13), as a sole anomaly. The second case presented simple chromosomal changes with involvement of the Xq23 chromosomal region, while a translocation t(X;11)(q23;q23) was also defined. Conclusions: The significance of the acquired pericentric inversion 9 in the development of the neoplastic process remains unknown. The chromosomal regions Xq23 and 11q23 need to be further investigated in association with clinicopathological parameters in ovarian cancer. The documentation of more ovarian cancer cases with simple chromosomal abnormalities is considered of major importance facilitating the identification of candidate genes involved in the neoplastic process. Improving the molecular understanding of ovarian cancer development and progression could facilitate the detection of specific tumour subtypes.

  • Ovarian cancer
  • chromosomes
  • simple structural chromosomal abnormalities
  • G-banding
  • acquired pericentric inversion 9

Ovarian cancer represents the leading cause of death among patients with gynaecological cancer. Patients with ovarian cancer are usually diagnosed at advanced disease stage. Most of the ovarian cancer cases described in the literature are characterized by complex chromosomal changes with polyploidization and structural chromosomal changes resulting usually in uncompleted karyotypes. However, non-random structural chromosomal aberrations have been found in ovarian cancer with common chromosomal breakpoints. Moreover, clinical associations with chromosomal abnormalities have been described in ovarian cancer patients (1-11). Two advanced stage ovarian cancer cases cytogenetically studied and showing simple chromosomal changes are hereby presented.

Materials and Methods

We reviewed on ascetic cancerous effusions samples cytogenetically studied. Since single chromosomal changes might be primary events implicated in the initiation or progression of the neoplastic process, we focused on single or simple structural chromosomal changes. Among cases studied, only two cases with a diagnosis of ovarian cancer presented simple chromosomal abnormalities. Both patients had never received chemotherapy or radiotherapy prior to cytogenetic study. Cytogenetic analysis was performed by direct culture of cancerous cells and a G-banding technique. Cancerous cells derived from ascetic fluids were immediately put into direct culture in Mc Coys 5A medium supplemented with fetal calf serum and colchicine. The cell suspension was incubated for 90 minutes at 37°C, then exposed to hypotonic treatment and fixation. The preparations were processed by the trypsin-Giemsa banding technique. As many cells as possible were analyzed in each case and not fewer than 15. An abnormal clone was defined as two or more cells with the same structural anomaly. Chromosomal aberrations were designed according to the International System for Human Cytogenetic Nomenclature (ISCN 1995) (12).

Results

The first case presented metaphases with a normal karyotype, while an abnormal clone of cells with a pericentric inversion of chromosome 9, inv(9)(p11q13), as a sole anomaly was also detected (Figure 1). The second case presented simple chromosomal changes with involvement of the sex chromosome X. In this case 3 metaphases had loss of sex chromosome X, while 4 metaphases presented a deletion of its long arm with a breakpoint at the Xq23 chromosomal region. Two of the metaphases with del(X)(q23) presented an abnormal chromosome 11 with an extra material on its long arm, which probably arose from the deleted segment of the sex chromosome X. Thus a translocation t(X;11)(q23;q23) was defined (Figure 2).

Discussion

The detection of recurrent chromosomal changes in solid tumors is extremely difficult. The tumors display complex chromosomal changes with various numerical and structural aberrations, while the presence of simple chromosomal abnormalities is a rare finding (13-15). In ovarian cancer recurrent abnormalities have been identified but today no specific aberration has been established (16).

A total of 31 cases of cytogenetically studied ovarian cancer have been previously reported by the authors (4-6), while approximately 35 additional ovarian cancer cases have been studied but not successfully karyotyped (not published). None of all these cases presented simple chromosomal changes. In the present study simple chromosomal changes in two advanced stage ovarian cancer cases are described. The first case had an abnormal clone with a pericentric inversion of chromosome 9, inv(9)(p11q13), as a sole anomaly, while in the second case simple chromosomal changes of the sex chromosome X with involvement of the chromosomal region Xq23 were found. Despite the notion that cancers accumulate more genetic abnormalities as they progress, in the present cases advanced ovarian cancer did not harbor complex chromosomal abnormalities.

Over the past four decades it has become clear that acquired non-random chromosomal abnormalities are associated with specific malignant diseases. Acquired chromosomal changes occur during life and are present in a specific tissue, while constitutional chromosomal abnormalities are either inherited from the parents or occur de novo during gametogenesis and they are present in all tissues. Familial pericentric inversion of chromosome 9 inv(9)(p11q13) is the most frequent pericentric inversion in man, with an incidence of 1% in the general population (17). Since the chromosomal breakpoints are in repetitive sequences this pericentric inversion of chromosome 9 is considered clinically insignificant (18). To date an acquired pericentric inversion of chromosome 9 has been reported in only 3 cases of hematologic malignant diseases, the significance of which remains unknown (18, 19). Betz et al. (18) supposed that the breakpoints of the acquired inversion 9 seen in hematologic malignancy might have occurred in euchromatin distal to the repeat sequences involved in the familial pericentric inversion 9, potentially leading to disruption of a gene implicated in the pathogenesis of the neoplastic disorder. The case presented here is the first case of ovarian cancer with an acquired inversion of chromosome 9. Until additional cases of ovarian cancer or other cancers with acquired inversion 9 are reported, the significance of this abnormality in the development of the neoplastic process will remain unknown.

The second case presented simple chromosomal changes with either loss of the sex chromosome X or structural abnormalities involving the chromosomal region Xq23. In this case a translocation t(X;11)(q23;q23) was also defined. Deletion del(X)(q23) has been previously reported in 4 cases of ovarian cancer with complex karyotypes (16).

It is considered that some chromosomal abnormalities may be responsible for the initiation or progression of a malignant disease. Since single chromosomal changes might be primary events implicated in the initiation of the neoplastic process the involvement of the chromosomal region Xq23 in the case described here might facilitate the identification of candidate genes involved in this malignant disease. Furthermore, in this case a translocation t(X;11)(q23;q23) was also defined. A preferential involvement of chromosome 11 as add(11)(q23) in ovarian cancer cases with complex karyotypes has been previously reported (4, 6). Moreover, loss of heterozigosity (LOH) has been demonstrated frequently at defined regions of chromosome 11 including 11q23-q25. It has also been reported that the frequency of LOH at 11p15 and 11q23 is significantly higher in advanced-stage tumours than in lower-stage tumours, while LOH at 11p15 and 11q23 was found to be associated with an adverse disease course in ovarian cancer. The presence of LOH at 11q23 suggests that chromosome 11 contains several tumour suppressor genes involved in ovarian cancer (20-23). To the authors' knowledge, abnormalities of chromosome 11 as add(11q23) have been described to date in 13 ovarian cancer cases (4, 6, 16, 24-26). A number of genes have been mapped on 11q23 that might be target genes for the development of ovarian cancer. Although, add(11)(q23) may result in loss of genetic material from chromosome 11q, alterations of specific genes involved by the translocation t(X;11)(q23;q23) could not be excluded. The documentation of more ovarian cancer cases with simple structural chromosomal abnormalities is considered of major importance facilitating the identification of candidate genes involved in the neoplastic process.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Karyotype from case No 1 showing a pericentric inversion of chromosome 9, inv(9)(p11q13).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Karyotype from case No 2 showing the translocation t(X;11)(q23;q23).

Tumorigenesis is a multistep process and chromosomal abnormalities have been shown to be implicated in the development or progression of tumours. Data of the present study support the possible role of both del(X)(q23) and the translocation t(X;11)(q23;q23) in ovarian cancer. The chromosomal regions Xq23 and 11q23 need to be further investigated in association with clinico-pathological parameters in ovarian cancer. Improving the molecular understanding of ovarian cancer development and progression could facilitate the detection of specific tumour subtypes, contributing also to novel strategies for the management of ovarian cancer patients.

  • Received December 2, 2008.
  • Revision received January 19, 2009.
  • Accepted February 13, 2009.
  • Copyright © 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Lynch HT,
    2. Casey MJ,
    3. Lynch J,
    4. White T,
    5. Godwin AK
    : Genetics and ovarian carcinoma. Semin Oncol 25: 265-280, 1998.
    OpenUrlPubMed
    1. Wang N
    : Cytogenetics and molecular genetics of ovarian cancer. Am J Med Genet (Semin Med Genet) 115: 157-163, 2002.
    OpenUrlPubMed
    1. Taetle R,
    2. Aickin M,
    3. Yang J-M,
    4. Panda L,
    5. Emerson J,
    6. Roe D,
    7. Adair L,
    8. Thompson F,
    9. Liu Y,
    10. Wisner L,
    11. Davis JR,
    12. Trent J,
    13. Alberts DS
    : Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25: 290-300, 1999.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Panani AD,
    2. Roussos C
    : Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality. Cancer Lett 235: 130-135, 2006.
    OpenUrlPubMed
    1. Panani AD,
    2. Ferti A
    : Common marker chromosomes in ovarian cancer. Cancer Genet Cytogenet 16: 65-71, 1985.
    OpenUrlPubMed
  3. ↵
    1. Panani AD
    : Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer? Cancer Lett 258: 262-267, 2007.
    OpenUrlPubMed
    1. Israeli O,
    2. Gotlieb WH,
    3. Friedman E,
    4. Korach J,
    5. Friedman E,
    6. Goldman B,
    7. Zeltser A,
    8. Ben-Baruch G,
    9. Rienstein S,
    10. Aviram-Goldring A
    : Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet Cytogenet 154: 16-21, 2004.
    OpenUrlCrossRefPubMed
    1. Bayani J,
    2. Brenton JD,
    3. Macgrecor PF,
    4. Beheshti B,
    5. Albert M,
    6. Nallainathan D,
    7. Karaskova J,
    8. Rosen B,
    9. Murphy J,
    10. Laframboise S,
    11. Zanke B,
    12. Squire JA
    : Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridisation and expression microarrays. Cancer Res 62: 3466-3476, 2002.
    OpenUrlAbstract/FREE Full Text
    1. Hu J,
    2. Khanna V,
    3. Jones MW,
    4. Surti U
    : Comparative study of primary and recurrent ovarian serous carcinomas: Comparative genomic hybridisation analysis with a potential application for prognosis. Gynecol Oncol 89: 369-375, 2003.
    OpenUrlCrossRefPubMed
    1. Sham JST,
    2. Tang TCM,
    3. Fang Y,
    4. Sun L,
    5. Qin L-X,
    6. Wu Q-L,
    7. Xie D,
    8. Guan X-Y
    : Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet Cytogenet 133: 39-44, 2002.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Taetle R,
    2. Aickin M,
    3. Panda L,
    4. Emerson J,
    5. Roe D,
    6. Thompson F,
    7. Davis J,
    8. Trent J,
    9. Alberts D
    : Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases. Genes Chromosomes Cancer 25: 46-52, 1999.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Mitelman F
    (ed.): (ISCN 1995) An International system for human cytogenetic nomenclature. Basel S. Karger, 1995.
  6. ↵
    1. Panani AD,
    2. Ferti A,
    3. Malliaros S,
    4. Raptis S
    : Cytogenetic study of 11 gastric adenocarcinomas. Cancer Genet Cytogenet 81: 169-172, 1995.
    OpenUrlPubMed
    1. Panani AD,
    2. Ferti A,
    3. Malliaros S,
    4. Raptis S
    : Gastric cancer with an i(8q) and long survival. Cancer Genet Cytogenet 58: 214-215, 1992.
    OpenUrlPubMed
  7. ↵
    1. Ochi H,
    2. Takeuchi J,
    3. Douglass H,
    4. Sandberg AA
    : Trisomy X as a possible initial chromosome change in a gastric cancer. Cancer Genet Cytogenet 12: 57-61, 1984.
    OpenUrlPubMed
  8. ↵
    1. Mitelman F,
    2. Johansson B,
    3. Mertens F
    : Mitelman Database of Chromosome Aberration in Cancer. (2006) http://cgap.nci.nih.gov./Chromosomes/Mitelman.
  9. ↵
    1. Jacobs PA,
    2. Browne C,
    3. Gregson N,
    4. Joyce C,
    5. White H
    : Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 29: 103-108, 1992.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Betz JL,
    2. Behairy AS,
    3. Rabionet P,
    4. Tirtorahardjo B,
    5. Moore MW,
    6. Cotter PD
    : Acquired inv (9): what is its significance? Cancer Genet Cytogenet 160: 76-78, 2005.
    OpenUrlPubMed
  11. ↵
    1. Wan TS,
    2. MA SK,
    3. Chan LC
    : Acquired pericentric inversion of chromosome 9 in essential thrombocythemia. Human Genet 106: 669-670, 2000.
    OpenUrlPubMed
  12. ↵
    1. Launonen V,
    2. Mannermaa A,
    3. Stenback F,
    4. Kosma VM,
    5. Puistola U,
    6. Huusko P,
    7. Anttila M,
    8. Bloigu R,
    9. Saarikoski S,
    10. Kauppila A,
    11. Winqvist R
    : Loss of heterozigosity at chromosomes 3,6,8,11,16 and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet 122: 49-54, 2000.
    OpenUrlCrossRefPubMed
    1. Stronach EA,
    2. Sellar GC,
    3. Blenkiron C,
    4. Rabiasz GJ,
    5. Taylor KJ,
    6. Miller EP,
    7. Massie CE,
    8. Al-Nafussi A,
    9. Smyth JF,
    10. Porteous DJ,
    11. Gabra H
    : Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 63: 8648-8655, 2003.
    OpenUrlAbstract/FREE Full Text
    1. Cabra H,
    2. Taylor R,
    3. Cohen BB,
    4. Lessels A,
    5. Eccles DM,
    6. Leonard RCF,
    7. Smyth JF,
    8. Steel CM
    : Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumors. Br J Cancer 72: 367-375, 1995.
    OpenUrlPubMed
  13. ↵
    1. Cabra H,
    2. Watson JEV,
    3. Taylor KJ,
    4. MacKay J,
    5. Leonard RCF,
    6. Steel CM,
    7. Porteous DJ,
    8. Smyth JF
    : Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950-954, 1996.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Jenkins PB,
    2. Bartelt DJr,
    3. Stalboerger P,
    4. Persons D,
    5. Dahl RJ,
    6. Podratz K,
    7. Keeney G,
    8. Hartmann L
    : Cytogenetic studies in epithelial ovarian carcinoma. Cancer Genet Cytogenet 71: 76-86, 1993.
    OpenUrlCrossRefPubMed
    1. Thompson FH,
    2. Emerson J,
    3. Alberts D,
    4. Liu Y,
    5. Guan X-Y,
    6. Burgess A,
    7. Fox S,
    8. Taetle R,
    9. Weinstein R,
    10. Makar R,
    11. Powell D,
    12. Trent J
    : Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 73: 33-45, 1994.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Pejovic T,
    2. Heim S,
    3. Mandahl N,
    4. Baldetorp B,
    5. Elmfors B,
    6. Floderus U-M,
    7. Furgyik S,
    8. Heim G,
    9. Himmelmann A,
    10. Willen H,
    11. Mitelman F
    : Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4: 58-68, 1992.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

In Vivo
Vol. 23, Issue 3
May-June 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Simple Structural Chromosomal Abnormalities in Advanced Stage of Ovarian Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Simple Structural Chromosomal Abnormalities in Advanced Stage of Ovarian Cancer
ANNA D. PANANI, CHRISTOS ARAVIDIS, ZOE KOSMAIDOU, ALEXANDROS RODOLAKIS, ARISTIDES ANTSAKLIS
In Vivo May 2009, 23 (3) 425-428;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Simple Structural Chromosomal Abnormalities in Advanced Stage of Ovarian Cancer
ANNA D. PANANI, CHRISTOS ARAVIDIS, ZOE KOSMAIDOU, ALEXANDROS RODOLAKIS, ARISTIDES ANTSAKLIS
In Vivo May 2009, 23 (3) 425-428;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Novel der(16)t(3;16)(p25;q24) in a Patient with Ovarian Cancer
  • Google Scholar

More in this TOC Section

  • Evaluation of the Relationship Between miRNA-22-3p and Gal-9 Levels in Glioblastoma
  • Metformin Inhibits the Estrogen-mediated Epithelial-Mesenchymal Transition of Ectopic Endometrial Stromal Cells in Endometriosis
  • MCC950 Ameliorates Acute Exogenous Lipoid Pneumonia Induced by Sewing Machine Oil in Rats via the NF-κB/NLRP3 Inflammasome Pathway
Show more Experimental Studies

Similar Articles

In Vivo

© 2023 In Vivo

Powered by HighWire